Cardiff Oncology Inc (CRDF)

Nov 20, 2024

Cardiff Oncology secures patent for cancer drug combo - Investing.com India

Nov 20, 2024

Nov 20, 2024

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC - GlobeNewswire

Nov 20, 2024

Nov 19, 2024

CRDFCardiff Oncology, Inc. Latest Stock News & Market Updates - StockTitan

Nov 19, 2024

Nov 19, 2024

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS ... - News-Press Now

Nov 19, 2024

Nov 19, 2024

Cardiff Oncology Secures Patent for Cancer Drug Combo Through 2043 | CRDF Stock News - StockTitan

Nov 19, 2024

Nov 12, 2024

Cardiff Oncology: Q3 Earnings Snapshot - AOL

Nov 12, 2024

Nov 09, 2024

HC Wainwright Has Lowered Expectations for Cardiff Oncology (NASDAQ:CRDF) Stock Price - MarketBeat

Nov 09, 2024

Nov 09, 2024

Cardiff Oncology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Cardiff Oncology Reports Positive Q3 2024 Results and Clinical Progress - TipRanks

Nov 08, 2024

Nov 08, 2024

Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 08, 2024

Nov 07, 2024

Cardiff Oncology Reports 7.7x Better Results in Phase 2 Cancer Trial, $57.7M Cash Position | CRDF Stock News - StockTitan

Nov 07, 2024

Nov 07, 2024

Cardiff Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Cardiff Oncology: Some Data Are In; Here's What You Should Know And Look For Next - Seeking Alpha

Nov 07, 2024

Nov 03, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Nov 03, 2024

Nov 02, 2024

Cardiff Oncology (FRA:XE7C) Float Percentage Of Total Shares Outstanding : 97.27% (As of Nov. 02, 2024) - GuruFocus.com

Nov 02, 2024

Nov 01, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Up 7.2% in October - MarketBeat

Nov 01, 2024

Oct 30, 2024

Cardiff Oncology Announces Journal of Clinical Oncology - GlobeNewswire

Oct 30, 2024

Oct 30, 2024

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - StockTitan

Oct 30, 2024

Oct 29, 2024

Alley Investment Management Company LLC Purchases New Stake in NVIDIA Co. (NASDAQ:NVDA) - Defense World

Oct 29, 2024

Oct 25, 2024

NA Liquid Biopsy Market 2024 To Witness Amazing Growth By 2032 - openPR

Oct 25, 2024

Oct 24, 2024

3 US Penny Stocks With Market Caps Over $40M - Simply Wall St

Oct 24, 2024

Oct 22, 2024

JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain - The Malaysian Reserve

Oct 22, 2024

Oct 15, 2024

KRAS Inhibitors Market Poised to Reach $157.6 Million by 2031, Driven by 5.61% CAGR As Revealed In New Report - WhaTech

Oct 15, 2024

Oct 14, 2024

Will Cardiff Oncology's Onvansertib Data Boost Its Stock Price? - RTTNews

Oct 14, 2024

Oct 10, 2024

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Oct 10, 2024

Oct 10, 2024

Cardiff Oncology Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Oct 10, 2024

Oct 09, 2024

Cardiff Oncology Inc (CRDF) Q2 2024 Earnings Call Highlights: Strategic Trials and Financial ... - Yahoo Finance

Oct 09, 2024

Oct 09, 2024

Neuroendocrine Tumors Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Oct 09, 2024

Oct 09, 2024

We're Keeping An Eye On Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Rate - Simply Wall St

Oct 09, 2024

Oct 08, 2024

Its Stock Has Paid Off Big Time For Cardiff Oncology Inc - SETE News

Oct 08, 2024

Oct 07, 2024

Stock Performance Spotlight: Cardiff Oncology Inc (CRDF) Ends the Day at 2.60, Up by 2.77 - The Dwinnex

Oct 07, 2024

Oct 07, 2024

CRDF (Cardiff Oncology Inc) has impressive results - US Post News

Oct 07, 2024

Oct 04, 2024

Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha

Oct 04, 2024

Oct 03, 2024

Take off with Cardiff Oncology Inc (CRDF): Get ready for trading - SETE News

Oct 03, 2024

Oct 02, 2024

Market Insight: Cardiff Oncology Inc (CRDF)’s Notable Drop, Closing at 2.47 - The Dwinnex

Oct 02, 2024

Oct 02, 2024

How to interpret Cardiff Oncology Inc (CRDF)’s stock chart patterns - US Post News

Oct 02, 2024

Oct 02, 2024

PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - The Malaysian Reserve

Oct 02, 2024

Oct 01, 2024

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Sunbelt Securities Inc. - Defense World

Oct 01, 2024

Sep 30, 2024

KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight - 新浪香港

Sep 30, 2024

Sep 27, 2024

IGC Pharma, Inc. (NYSEMKT:IGC) Director Buys $199,999.90 in Stock - Defense World

Sep 27, 2024

Sep 26, 2024

Blair William & Co. IL Raises Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Sep 26, 2024

Sep 26, 2024

Delta Investment Management LLC Cuts Stock Position in JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST) - Defense World

Sep 26, 2024

Sep 25, 2024

Cardiff City . . . The Doom Loop Club Stuck On Groundhog Day - Dai Sport

Sep 25, 2024

Sep 25, 2024

Investment Opportunities: Capitalizing on the Global Kras - openPR

Sep 25, 2024

Sep 25, 2024

Cardiff City need 'long-term strategy' after Erol Bulut exitRob Earnshaw - BBC.com

Sep 25, 2024

Sep 24, 2024

Tonight's Cardiff City news as 'stunned' club release statement and pundit picks 'fantastic' fit for job - Yahoo News UK

Sep 24, 2024

Sep 24, 2024

Trading Day Review: Cardiff Oncology Inc (CRDF) Loses Momentum, Closing at 2.58 - The Dwinnex

Sep 24, 2024